Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2019 | Erythropoietin in AHA patients

Anita Hill • 13 Jun 2019
EHA 2019
Anemias Aplastic Anemia

Anita Hill, MBChB (Hons), MRCP, FRCPath, PhD, Leeds Teaching Hospital NHS Trust, Leeds, UK, discusses the use of erythropoietin in patients with autoimmune hemolytic anemia at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

More from Anita Hill

1:29
Treating Patients with PNH and AA
Anita Hill • 13 Jun 2019
2:05
Anita Hill: highlights from EHA 2019
Anita Hill • 13 Jun 2019
1:40
PNH treatment: ravulizumab vs. eculizumab
Anita Hill • 13 Jun 2019
1:50
SAA treatment and QoL
Anita Hill • 13 Jun 2019

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
3:45
A 2-year analysis of the EBMT-SAAWP RACE trial: eltrombopag in aplastic anemia
Antonio Risitano • 16 Apr 2024
1:31
Mitapivat improves work/school attendance in patients with pyruvate kinase deficiency
Hanny Al-Samkari • 9 Dec 2023
2:13
SATISFY: mitapivat in patients with erythrocyte membranopathies
Kevin Kuo • 10 Dec 2023
The content of VJHemOnc is intended for healthcare professionals